High-dose PMA with RANKL and MCSF induces THP‑1 cell differentiation into human functional osteoclasts in vitro

Li,Zhuo Hao; Si,Yu; Xu,Guo; Chen,Xi Ming; Xiong,Hao; Lai,Lan; Zheng,Yi Qing; Zhang,Zhi Gang

doi:10.3892/mmr.2017.7625

December-2017 Volume 16 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

December-2017 Volume 16 Issue 6

Full Size Image

Article

High-dose PMA with RANKL and MCSF induces THP‑1 cell differentiation into human functional osteoclasts in vitro

Authors:
- Zhuo Hao Li
- Yu Si
- Guo Xu
- Xi Ming Chen
- Hao Xiong
- Lan Lai
- Yi Qing Zheng
- Zhi Gang Zhang
View Affiliations / Copyright

Affiliations: Department of Otolaryngology Head and Neck Surgery, Sun Yat‑sen Memorial Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510120, P.R. China
Pages: 8380-8384
|
Published online on: September 26, 2017

https://doi.org/10.3892/mmr.2017.7625
Expand metrics +

Abstract

Osteoclasts are large multinuclear cells, which serve role in erosive bone disease. However, it is not possible to separate osteoclasts from cortical bone in order to culture the cells for further experiments. Therefore, a human osteoclast model is required to investigate the underlying mechanism of bone destruction. The most commonly‑used osteoclast model is the RAW264.7 cell line, a murine mononuclear macrophage cell line; however, there exists no reliable osteoclast model using a human cell line. The aim of the present study was to establish a functional osteoclast model using the THP‑1 cell line. Suspended THP‑1 cells were stimulated for 2 days with 5 or 100 ng/ml phorbol‑12 myristate‑13 acetate (PMA) in order to induce the cells to differentiate into adherent macrophages. A 10‑day stimulation with 50 ng/ml receptor activator of nuclear factor κ‑B ligand (RANKL) and macrophage colony‑stimulating factor (MCSF) was performed in order to induce macrophage differentiation into osteoclasts. Treatment with high‑dose PMA with RANKL and MCSF enabled the THP‑1 cells to form tartrate‑resistant acid phosphatase‑positive osteoclasts, which were able absorb bone in a bone resorption test. Treatment with low‑dose PMA with RANKL and MCSF failed to induce THP‑1 cell differentiation into osteoclasts. PMA alone, or a combination of RANKL and MCSF alone, is insufficient to stimulate THP‑1 cell differentiation into osteoclasts. In the present study, a reliable human osteoclast model was established using the THP‑1 cell line. This osteoclast model may provide a useful tool for further studies.

View Figures

View References

1	Soares-Schanoski A, Gómez-Piña V, del Fresno C, Rodríguez-Rojas A, García F, Glaría A, Sánchez M, Vallejo-Cremades MT, Baos R, Fuentes-Prior P, et al: 6-Methylprednisolone down-regulates IRAK-M in human and murine osteoclasts and boosts bone-resorbing activity: A putative mechanism for corticoid-induced osteoporosis. J Leukoc Biol. 82:700–709. 2007. View Article : Google Scholar : PubMed/NCBI
2	Charles JF and Aliprantis AO: Osteoclasts: More than ‘bone eaters’. Trends Mol Med. 20:449–459. 2014. View Article : Google Scholar : PubMed/NCBI
3	Sloan AJ, Taylor SY, Smith EL, Roberts JL, Chen L, Wei XQ and Waddington RJ: A novel ex vivo culture model for inflammatory bone destruction. J Dent Res. 92:728–734. 2013. View Article : Google Scholar : PubMed/NCBI
4	Flecher X, Rolland C, Rixrath E, Argenson JN, Robert P, Bongrand P, Wendling S and Vitte J: Local and systemic activation of the mononuclear phagocyte system in aseptic loosening of total hip arthroplasty. J Clin Immunol. 29:681–690. 2009. View Article : Google Scholar : PubMed/NCBI
5	Crump TB, Wimmer KL, Reinhardt AL, Schmid MJ, Meyer CR, Robinson DH, Marx DB, Bhattacharyya I and Reinhardt RA: Effects of locally-delivered human macrophage products and estrogen on murine inflammatory bone resorption. J Periodontal Res. 37:101–109. 2002. View Article : Google Scholar : PubMed/NCBI
6	Lee HP, Lin YY, Duh CY, Huang SY, Wang HM, Wu SF, Lin SC, Jean YH and Wen ZH: Lemnalol attenuates mast cell activation and osteoclast activity in a gouty arthritis model. J Pharm Pharmacol. 67:274–285. 2015. View Article : Google Scholar : PubMed/NCBI
7	Kawamura H, Arai M and Togari A: Inhibitory effect of chlorpromazine on RANKL-induced osteoclastogenesis in mouse bone marrow cells. J Pharmacol Sci. 117:54–62. 2011. View Article : Google Scholar : PubMed/NCBI
8	Ueki Y, Lin CY, Senoo M, Ebihara T, Agata N, Onji M, Saheki Y, Kawai T, Mukherjee PM, Reichenberger E and Olsen BR: Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 ‘cherubism’ mice. Cell. 128:71–83. 2007. View Article : Google Scholar : PubMed/NCBI
9	Jung YK, Han SW, Kim GW, Jeong JH, Kim HJ and Choi JY: DICAM inhibits osteoclast differentiation through attenuation of the integrin αVβ3 pathway. J Bone Miner Res. 27:2024–2034. 2012. View Article : Google Scholar : PubMed/NCBI
10	Petrova NL, Petrov PK, Edmonds ME and Shanahan CM: Novel use of a Dektak 150 surface profiler unmasks differences in resorption pit profiles between control and Charcot patient osteoclasts. Calcif Tissue Int. 94:403–411. 2014. View Article : Google Scholar : PubMed/NCBI
11	Uchiyama S and Yamaguchi M: Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol. 67:1297–1305. 2004. View Article : Google Scholar : PubMed/NCBI
12	Park EK, Jung HS, Yang HI, Yoo MC, Kim C and Kim KS: Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm Res. 56:45–50. 2007. View Article : Google Scholar : PubMed/NCBI
13	Tundup S, Srivastava L, Nagy T and Harn D: CD14 influences host immune responses and alternative activation of macrophages during Schistosoma mansoni infection. Infect Immun. 82:3240–3251. 2014. View Article : Google Scholar : PubMed/NCBI
14	Yang RF, Zhao GW, Liang ST, Chen HZ and Liu DP: Lysine-specific demethylase 1 represses THP-1 monocyte-to-macrophage differentiation. Chin Med Sci J. 28:82–87. 2013. View Article : Google Scholar : PubMed/NCBI
15	Pivetta E, Wassermann B, Bulian P, Steffan A, Colombatti A, Polesel J and Spessotto P: Functional osteoclastogenesis: The baseline variability in blood donor precursors is not associated with age and gender. Oncotarget. 6:31889–31900. 2015. View Article : Google Scholar : PubMed/NCBI
16	Ritchlin CT, Haas-Smith SA, Li P, Hicks DG and Schwarz EM: Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest. 111:821–831. 2003. View Article : Google Scholar : PubMed/NCBI
17	Wang Y, Dong G, Jeon HH, Elazizi M, La LB, Hameedaldeen A, Xiao E, Tian C, Alsadun S, Choi Y and Graves DT: FOXO1 mediates RANKL-induced osteoclast formation and activity. J Immunol. 194:2878–2887. 2015. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

High-dose PMA with RANKL and MCSF induces THP‑1 cell differentiation into human functional osteoclasts in vitro

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Related Articles